Clément Thomas
Latest publications
Higher incidence of B cell malignancies in primary immunodeficiencies: A combination of intrinsic genomic instability and exocytosis defects at the immunological synapse.
- Cytoskeleton and Cancer Progression
2020 Nov. Front Immunol.11:581119.
Escape of tumor cells from the NK cell cytotoxic activity.
- Cytoskeleton and Cancer Progression
2020 Oct. J Leukoc Biol.108(4):1339-1360. Epub 2020 Sep 15.
Actin remodeling and vesicular trafficking at the tumor cell side of the immunological synapse direct evasion from cytotoxic lymphocytes.
- Cytoskeleton and Cancer Progression
- Tumor Stroma Interactions
2020 Sep. Int Rev Cell Mol Biol.356:99-130. Epub 2020 Sep.
Actin cytoskeleton straddling the immunological synapse between cytotoxic lymphocytes and cancer cells.
- Cytoskeleton and Cancer Progression
2019 May. Cells.8(5).
Do tumor cells escape from natural killer cell cytotoxicity by mimicking dendritic cells?
- Cytoskeleton and Cancer Progression
2019 Mar. Oncotarget.10(25):2419-2420.
Actin cytoskeleton remodeling drives breast cancer cell escape from natural killer-mediated cytotoxicity.
- Cytoskeleton and Cancer Progression
- Platform National Cytometry
- NORLUX Neuro-Oncology Laboratory
- Tumor Immunotherapy and Microenvironment
2018 Oct. Cancer Res.78(19):5631-5643. Epub 2018 Aug 13.
Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2.
- Cytoskeleton and Cancer Progression
- Tumor Immunotherapy and Microenvironment
2018 Jul. Sci Rep.8(1):10191.
Subcellular localization and function of 2LIM proteins in plants and humans.
- Cytoskeleton and Cancer Progression
2017 Dec. Planta.246(6):1243-1245. Epub 2017 Oct 9.
TWISTED DWARF1 mediates the action of auxin transport inhibitors on actin cytoskeleton dynamics.
- Cytoskeleton and Cancer Progression
2016 Apr. Plant Cell.28(4):930-48. Epub 2016 Apr 6.
CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
- Cytoskeleton and Cancer Progression
- NORLUX Neuro-Oncology Laboratory
2016 Mar. Oncotarget.7(12):13688-705.
The pH sensibility of actin-bundling LIM proteins is governed by the acidic properties of their C-terminal domain.
- Cytoskeleton and Cancer Progression
- NORLUX Neuro-Oncology Laboratory
- DNA Repair and Chemoresistance
2015 Aug. FEBS Lett.589(18):2312-9. Epub 2015 Jul 29.
Hypoxia: A key feature of the tumor microenvironment triggers several mechanisms of evasion from natural killer and cytotoxic T lymphocytes surveillance.
- Tumor Immunotherapy and Microenvironment
- Tumor Stroma Interactions
- Cytoskeleton and Cancer Progression
2014 Nov. J Imm Res.1(2):7.
Human muscle LIM protein dimerizes along the actin cytoskeleton and cross-links actin filaments.
- Cytoskeleton and Cancer Progression
- Cardiovascular Research Unit
2014 Aug. Mol Cell Biol.34(16):3053-65. Epub 2014 Jun 16.
A dynamic interplay between membranes and the cytoskeleton critical for cell development and signaling.
- Cytoskeleton and Cancer Progression
2014 Jul. Front Plant Sci.5:335.
Live cell imaging reveals actin-cytoskeleton-induced self-association of the actin-bundling protein WLIM1.
- Cytoskeleton and Cancer Progression
2014 Feb. J Cell Sci.127(Pt 3):583-98. Epub 2013 Nov 27.
A LIM domain protein from tobacco involved in actin-bundling and histone gene transcription.
- Cytoskeleton and Cancer Progression
2013 Mar. Mol Plant.6(2):483-502. Epub 2012 Aug 28.
Bundling actin filaments from membranes: some novel players.
- Cytoskeleton and Cancer Progression
2012 Aug. Front Plant Sci.3:188. Epub 2012 Aug 24.
Arabidopsis actin-depolymerizing factors (ADFs) 1 and 9 display antagonist activities.
- Cytoskeleton and Cancer Progression
2011 Jun. FEBS Lett.585(12):1821-7. Epub 2011 May 11.
Arabidopsis LIM proteins: a family of actin bundlers with distinct expression patterns and modes of regulation.
- Cytoskeleton and Cancer Progression
2010 Sep. Plant Cell.22(9):3034-52. Epub 2010 Sep 3.